Related Experiment Video
Updated: Nov 21, 2025

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Changes in Body Weight and Concurrent Changes in Cardiovascular Risk Profiles in Community Residents in Japan: the
Takanori Honda1, Yuki Ishida1, Masaaki Oda2
1Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University.
Losing weight benefits obese individuals by reducing cardiovascular disease (CVD) risk. Avoiding weight gain is crucial for nonobese individuals to maintain cardiovascular health.
Area of Science:
- Cardiovascular disease research
- Obesity studies
- Public health interventions
Background:
- Weight change significantly impacts cardiovascular disease (CVD) risk.
- Understanding weight trajectories is key to managing CVD risk factors.
- Community-based studies provide real-world insights into health behaviors.
Purpose of the Study:
- To investigate how weight change influences predicted cardiovascular disease (CVD) risk.
- To examine concurrent changes in individual CVD risk factors over time.
- To assess the impact of different weight trajectories on health outcomes.
Main Methods:
- Analysis of 2,140 community-dwellers aged 40-74 years with data from 2002 and 2007.
- Classification of weight trajectories: stable obese, obese to nonobese, nonobese to obese, stable nonobese.
- Comparison of model-predicted CVD risk and individual risk factors across weight-change categories.
Main Results:
- Predicted CVD risk increased over 5 years in all groups.
- The "obese to nonobese" group showed the smallest increase in CVD risk.
- Weight loss in obese individuals and weight maintenance in nonobese individuals led to favorable changes in CVD risk factors.
Conclusions:
- Losing weight is favorably associated with reduced future CVD risk in obese individuals.
- Avoiding excessive weight gain is important for nonobese individuals to mitigate CVD risk.
- Findings support enhancing lifestyle interventions with weight change health consequences information.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
07:44Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
Published on: July 14, 2023
Related Concept Videos
Factors affecting Blood pressure
Physiological Factors:
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...